News Sentiment

QTRX sentiment intelligence

Quanterix Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 51 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 3.88 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-10.4% over one week, +25.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Quanterix Corporation (QTRX) Gains on Coverage Announcement for Alzheimer's Test

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -10.4% Price reacting lower
Trend fit Trend inactive 25.2% over four weeks
Fair value -68.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 49
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
Stock Titan 11
Investing.com 5
Business Wire 5
TradingView 5
MT Newswires 3
GuruFocus 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 41
Earnings 20
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 63
Seeking Alpha Direct company coverage

Quanterix wins coverage for Alzheimer’s test (QTRX:NASDAQ)

Quanterix Corporation saw a ~3% increase in premarket trading after announcing that its Alzheimer’s test, LucentAD Complete, will be covered by Elevance Health’s Anthem Blue Cross and Blue Shield health plans starting this month. This coverage is expected to expand access to the

Tone
Positive 71/100
Event
Market update
Published
15 Jul 2026 12:40
Source
Seeking Alpha
Investing.com Direct company coverage

Anthem Blue Cross covers Quanterix Alzheimer’s blood test

Anthem Blue Cross and Blue Shield will now cover Quanterix Corporation's LucentAD Complete blood-based biomarker test for Alzheimer's disease for its 40 million members, effective July 1, 2026. This announcement led to a 5% increase in Quanterix's stock. The company also highligh

Tone
Positive 69/100
Event
Market update
Published
15 Jul 2026 02:40
Source
Investing.com
Stock Titan Direct company coverage

Quanterix test found preclinical Alzheimer’s evidence in 20% of cognitively normal adults

Quanterix announced that Anthem Blue Cross and Blue Shield will begin commercial coverage for its LucentAD® Complete blood test for Alzheimer's disease on July 1, 2026. This milestone, alongside a new peer-reviewed study and data presented at AAIC 2026, reinforces the clinical va

Tone
Positive 75/100
Event
Market update
Published
14 Jul 2026 20:13
Source
Stock Titan
Stock Titan Direct company coverage

Director Scott Mendel converts 8,073 RSUs at Quanterix (NASDAQ: QTRX)

Quanterix director Scott Mendel converted 8,073 restricted stock units (RSUs) into common shares on July 8, 2026, as part of a routine vesting event. Following this transaction, he directly holds 24,056 common shares and 16,391 remaining RSUs. The converted RSUs were part of a 24

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 20:40
Source
Stock Titan
Stock Titan Direct company coverage

Quanterix (QTRX) director converts 8,073 RSUs, now holds 15,041 shares

Quanterix Corp director Myla Lai-Goldman converted 8,073 restricted stock units (RSUs) into common shares, increasing her direct holdings to 15,041 shares. She still holds 16,391 RSUs which will convert into common stock on a one-for-one basis. These RSUs were part of a larger gr

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 08:09
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 4 Quanterix Corp For: 9 July By Investing.com

This article announces the filing of Form 4 for Quanterix Corp on July 9th. It is a brief corporate news update from Investing.com, typical of filings news. The article also includes various market data like indices, commodities, and share prices, along with trending news and sto

Tone
Negative 42/100
Event
Market update
Published
09 Jul 2026 22:22
Source
Investing.com Nigeria
Quartr Direct company coverage

Quanterix (QTRX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary

Quanterix (QTRX) presented at the Goldman Sachs 47th Annual Global Healthcare Conference in 2026, where the company highlighted its strategic shift from research tools to clinical diagnostics, particularly in Alzheimer's. Key points included plans for FDA approval of a multi-mark

Tone
Positive 69/100
Event
Regulatory and legal
Published
08 Jul 2026 21:10
Source
Quartr
Quartr Direct company coverage

Quanterix (QTRX) Q1 2025 earnings summary

Quanterix (QTRX) reported a Q1 2025 revenue of $30.3M, a 5% year-over-year decrease, with record consumables performance offset by softness in other segments, leading to a widened net loss of $20.5M. The company is prioritizing operational discipline and cost reductions to achiev

Tone
Negative 33/100
Event
Earnings
Published
08 Jul 2026 21:10
Source
Quartr
Simply Wall Street Direct company coverage

QTRX: Recalibrated Expectations Will Shape Long Term Alzheimer’s Blood Test Upside

Analysts have adjusted their price targets for Quanterix (QTRX), leading to a lower but still supported valuation range, primarily due to recalibrated expectations regarding fair value, discount rates, revenue growth, profit margins, and future P/E multiples. While some analysts

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 20:17
Source
Simply Wall Street
Stock Titan Direct company coverage

Quanterix (QTRX) director gets 5,472-share stock grant for Q2 2026 board fees

Quanterix (QTRX) director William P. Donnelly received a grant of 5,472 shares of common stock, valued at $4.34 per share, as compensation for his board service in Q2 2026, in lieu of cash fees. This transaction, categorized as a grant/award, increases his direct holdings to 160,

Tone
Neutral 50/100
Event
Balance sheet
Published
06 Jul 2026 08:41
Source
Stock Titan
www.marketscreener.com Direct company coverage

Quanterix Corporation(NasdaqGM: QTRX) dropped from Russell 3000E Growth Benchmark

Quanterix Corporation (NasdaqGM: QTRX) has been removed from the Russell 3000E Growth Benchmark. The article also provides recent news about the company, including management changes, quarterly earnings results, and presentations at financial conferences. It also includes financi

Tone
Negative 31/100
Event
Earnings
Published
30 Jun 2026 04:39
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Quanterix Corporation(NasdaqGM:QTRX) dropped from Russell Small Cap Comp Growth Benchmark

Quanterix Corporation (NasdaqGM:QTRX) has been removed from the Russell Small Cap Comp Growth Benchmark, as announced on June 29, 2026. This news comes alongside several recent updates for the company, including presentations at a Goldman Sachs conference and changes to its execu

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 21:10
Source
www.marketscreener.com
TradingView Direct company coverage

Quanterix Corporation Actuals & Estimates (NASDAQ:QTRX)

This article provides an overview of Quanterix Corporation (NASDAQ: QTRX) stock performance, financial actuals, and analyst estimates. It includes current stock price, recent performance trends, market capitalization, earnings estimates, revenue figures, and employee count. The a

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 04:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Quanterix Corporation – NASDAQ:QTRX

This article displays the "Enterprise value to EBITDA forward" metric for Quanterix Corporation (NASDAQ: QTRX) on TradingView. It provides financial data for the company under the Health Technology sector. The content itself is an excerpt from a financial data platform, showcasin

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 05:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Quanterix Corporation – NASDAQ:QTRX

This article displays financial information for Quanterix Corporation (NASDAQ: QTRX), specifically its enterprise value to revenue forward metric. It's presented within a TradingView interface, showing market data from various providers like ICE Data Services and FactSet. The con

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 09:11
Source
TradingView
TradingView Direct company coverage

QTRX Forecast — Price Target — Prediction for 2027

This article provides a forecast for Quanterix Corporation (QTRX) stock, including analyst price targets and predictions for 2027. It details recent stock performance, financial metrics like EPS and revenue, and upcoming earnings dates. The article also answers frequently asked q

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 08:39
Source
TradingView
Finviz Direct company coverage

QTRX - Quanterix Corp Volatility & Greeks

This article provides a detailed financial overview of Quanterix Corp (QTRX), including its stock performance, key financial metrics, and volatility data. It lists various ratios such as P/E, P/S, ROA, and highlights insider and institutional ownership, alongside short interest f

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 05:10
Source
Finviz
Sahm Direct company coverage

Quanterix Stock Is Popping In Pre-Market: Here's Why

Quanterix Corporation (NASDAQ: QTRX) stock surged 5.28% in pre-market trading after Securities and Exchange Commission filings revealed outgoing CFO Vandana Sriram vested and forfeited some restricted stock units. Jason Faessler officially assumed the CFO role, joining from Bruke

Tone
Positive 60/100
Event
Market update
Published
25 Jun 2026 15:39
Source
Sahm
TradingKey Direct company coverage

Quanterix Corp (QTRX) Valuation: PE, PB & Fair Value Analysis

Quanterix Corp (QTRX) currently holds a valuation score of 7.38, placing it 163rd out of 203 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -1.83, which is significantly below its recent high and above its recent low. Key valuation metrics like P/B, P

Tone
Negative 40/100
Event
Market update
Published
25 Jun 2026 14:39
Source
TradingKey
Ad-hoc-news.de Direct company coverage

Quanterix Corp sets out growth plans, shares trade on Nasdaq

Quanterix Corp is gaining investor attention with its digital biomarker platform and recent operational milestones, with its shares trading on Nasdaq. The company focuses on developing ultra-sensitive digital biomarker assays based on its proprietary Simoa technology, targeting p

Tone
Positive 75/100
Event
Market update
Published
25 Jun 2026 12:41
Source
Ad-hoc-news.de
TradingView Direct company coverage

Price to earnings forward of Quanterix Corporation – NASDAQ:QTRX

This article provides the "Price to earnings forward" metric for Quanterix Corporation (NASDAQ: QTRX). It indicates that the value and change percentages for this financial metric are made by humans and offers some context about the data providers. The main content focuses solely

Tone
Neutral 50/100
Event
Earnings
Published
24 Jun 2026 19:40
Source
TradingView
Stock Titan Direct company coverage

Quanterix (QTRX) CFO adds stock as RSUs vest and shares withheld

Quanterix CFO Vandana Sriram reported that 1,833 restricted stock units (RSUs) converted into common stock on June 15, 2026. Of these, 548 shares were withheld at $3.10 per share to cover tax obligations, which is a routine part of equity compensation. Following these transaction

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 14:39
Source
Stock Titan
Stocktwits Direct company coverage

TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today

Trinity Biotech (TRIB), Quanterix Corp. (QTRX), and Recon Technology (RCON) all experienced double-digit gains in after-hours trading. TRIB surged after launching Trinovium, a new subsidiary for liquid-cooling solutions for AI data centers. QTRX rose following the official appoin

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 07:40
Source
Stocktwits